ANVI GLOBAL HOLDINGS, INC. financial metrics
Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic.
Latest period: Q4 2025.
-
Symbol
-
ANVI on OTC
-
Location
-
Cary, NC
-
Fiscal year end
-
28 February
-
Latest financial report
-
14 Jan 2026
Latest SEC snapshot (2026-01-14) highlights Return On Equity 9.1%, Return On Assets -1320.8%, and Current Ratio 0.0x.
How Calculated (standard_v1)
Metrics are computed with a market-consensus convention designed for cross-portal comparability.
- TTM Operating Income / TTM Revenues
- Current Assets / Current Liabilities (latest instant quarter)
- (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
- Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
- TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
- TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
- TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
- TTM Revenues YoY
- TTM Net Income YoY
Financial Quality Score
Transparent 0-100 scoring model based on profitability, financial health, and growth factors.
7.1/100
Weak
Confidence medium
Return On Equity
9.1%
Metric score 6.6/100
Return On Assets
-1321%
Metric score 0.0/100
Financial Health
- Current Ratio
- 0x
- Debt to Equity
- -1x
Strengths
No strong signals yet.
Watchpoints
Return On Equity, Return On Assets, and Current Ratio
Financial Health
| Metric |
Latest value |
YoY change |
Calendar period |
Fiscal period |
Unit |
|
Current Ratio
|
0x
|
-91%
|
Q4 2025
|
Q3 2026
|
x
|
|
Debt-to-equity
|
-1x
|
-0.38%
|
Q4 2025
|
Q3 2026
|
x
|
Growth
| Metric |
Latest value |
YoY change |
Calendar period |
Fiscal period |
Unit |
|
NetIncomeLoss YoY
|
-0.91%
|
|
Q4 2025
|
Q3 2026
|
%
|
Share Metrics
| Metric |
Latest value |
YoY change |
Calendar period |
Fiscal period |
Unit |
|
Entity Common Stock, Shares Outstanding
|
119,950,000
|
0%
|
Q4 2025
|
Q3 2026
|
shares
|
|
Common Stock, Shares, Outstanding
|
119,950,000
|
0%
|
Q4 2025
|
Q3 2026
|
shares
|
|
Common Stock, Value, Issued
|
$119,950
|
0%
|
Q4 2025
|
Q3 2026
|
USD
|
|
Weighted Average Number of Shares Outstanding, Basic
|
119,950,000
|
0%
|
Q4 2025
|
Q3 2026
|
shares
|
|
Weighted Average Number of Shares Outstanding, Diluted
|
119,950,000
|
0%
|
Q4 2025
|
Q3 2026
|
shares
|
Additional Metrics
| Metric |
Latest value |
YoY change |
Calendar period |
Fiscal period |
Unit |
|
General and Administrative Expense
|
$201,832
|
+0.9%
|
Q4 2025
|
Q3 2026
|
USD
|
|
Operating Income (Loss)
|
$201,832
|
-0.9%
|
Q4 2025
|
Q3 2026
|
USD
|
|
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest
|
$201,832
|
-0.9%
|
Q4 2025
|
Q3 2026
|
USD
|
|
Income Tax Expense (Benefit)
|
$0
|
|
Q4 2025
|
Q3 2026
|
USD
|
|
Earnings Per Share, Basic
|
0
|
|
Q4 2025
|
Q3 2026
|
USD/shares
|
|
Earnings Per Share, Diluted
|
0
|
|
Q4 2025
|
Q3 2026
|
USD/shares
|
|
Assets, Current
|
$2,762
|
-90%
|
Q4 2025
|
Q3 2026
|
USD
|
|
Assets
|
$2,762
|
-90%
|
Q4 2025
|
Q3 2026
|
USD
|
|
Accounts Payable, Current
|
$14,170
|
-43%
|
Q4 2025
|
Q3 2026
|
USD
|
|
Accrued Liabilities, Current
|
$900,000
|
0%
|
Q4 2025
|
Q3 2026
|
USD
|
|
Liabilities, Current
|
$2,317,296
|
+8.3%
|
Q4 2025
|
Q3 2026
|
USD
|
|
Liabilities
|
$2,317,296
|
+8.3%
|
Q4 2025
|
Q3 2026
|
USD
|
|
Retained Earnings (Accumulated Deficit)
|
$2,373,034
|
-9.3%
|
Q4 2025
|
Q3 2026
|
USD
|
|
Stockholders' Equity Attributable to Parent
|
$2,314,534
|
-9.6%
|
Q4 2025
|
Q3 2026
|
USD
|
|
Liabilities and Equity
|
$2,762
|
-90%
|
Q4 2025
|
Q3 2026
|
USD
|
|
Common Stock, Shares Authorized
|
500,000,000
|
0%
|
Q4 2025
|
Q3 2026
|
shares
|
|
Common Stock, Shares, Issued
|
119,950,000
|
0%
|
Q4 2025
|
Q3 2026
|
shares
|
|
Common Stock, Par or Stated Value Per Share
|
0.001
|
0%
|
Q4 2025
|
Q3 2026
|
USD/shares
|
|
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
|
$1,457
|
-86%
|
Q4 2025
|
Q3 2026
|
USD
|
|
Preferred Stock, Shares Issued
|
0
|
|
Q4 2025
|
Q3 2026
|
shares
|
|
Preferred Stock, Shares Authorized
|
50,000,000
|
0%
|
Q4 2025
|
Q3 2026
|
shares
|
|
Preferred Stock, Shares Outstanding
|
0
|
|
Q4 2025
|
Q3 2026
|
shares
|
|
Preferred Stock, Par or Stated Value Per Share
|
0.001
|
0%
|
Q4 2025
|
Q3 2026
|
USD/shares
|
How we score
This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.
| Metric |
Weight |
V1 threshold |
| ROIC | 20 | 5% to 20% |
| ROE | 15 | 8% to 25% |
| ROA | 10 | 2% to 10% |
| Operating Margin | 5 | 5% to 25% |
| Current Ratio | 12 | 1.0x to 2.0x |
| Quick Ratio | 8 | 0.8x to 1.5x |
| Debt to Equity | 10 | 0.3x to 2.0x (lower is better) |
| Revenue YoY | 10 | -10% to +20% |
| Net Income YoY | 10 | -10% to +20% |
Explore related SEC datasets